Chennai: NephroPlus has expanded its footprint into the Commonwealth of Independent States (CIS) market.

The company has won the tender to build and operate the comprehensive dialysis program for Republic of Uzbekistan in a competitive international bidding process.

A press release here said, this ten-year tenured project will be signed between the Ministry of Health of the Republic of Uzbekistan and NephroPlus. This high value project is expected to generate a topline of Rs 750 – 800 crore over the project term.

The government of Uzbekistan awarded NephroPlus the bid to finance, construct, equip, train personnel, and operate four large dialysis centres in Tashkent, Karakalpakstan and Khorezm region with an aim to deliver quality dialysis services for over 1,100 patients.

For this project, NephroPlus will establish a 100 per cent owned local subsidiary, and the key resources from India will implement and supervise international standard clinical protocols to improve quality of dialysis care in the country.

As part of this contract, NephroPlus will be building the largest dialysis center in Asia to serve over 750 patients in the capital city of Tashkent.

Vikram Vuppala, founder and CEO, NephroPlus said, “We are excited to partner with the government of Uzbekistan to provide high quality and patient centric dialysis care in Uzbekistan. It is a matter of pride for us that NephroPlus was the only bidder from Asia and this outcome proves that Indian healthcare firms can compete with and win amongst very large global incumbents”.

Kamal D Shah, co-founder, NephroPlus, added, “This project will not only save many lives who are suffering from Kidney failure in Uzbekistan, but also improve their quality of life as NephroPlus has demonstrated in India for over a decade now. We look forward to offering a comprehensive suite of renal services in Uzbekistan including Incenter dialysis, Home dialysis, Fistula procedures, oversight of lab investigations and pharmacy services.”